AETHLON MEDICAL, INC. Amortization of Debt Discount (Premium)
AETHLON MEDICAL, INC. (AEMD) reported Amortization of Debt Discount (Premium) of $0 for the 9-month period ending 2020-12-31, per its 10-Q filed 2021-02-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2021-02-10
- AETHLON MEDICAL, INC. amortization of debt discount (premium) for the quarter ending 2020-12-31 was $0.00.
- AETHLON MEDICAL, INC. amortization of debt discount (premium) for the quarter ending 2020-09-30 was $0.00.
- AETHLON MEDICAL, INC. amortization of debt discount (premium) for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- AETHLON MEDICAL, INC. amortization of debt discount (premium) for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 6 month as first filed | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-10 | $0.00 derived: sum of 2 quarters · filed 2021-02-10 | $0.00 10-Q · filed 2021-02-10 | ||
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-28 | $0.00 10-Q · filed 2020-10-28 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-11 | ||||
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-10 | $0.00 derived: sum of 2 quarters · filed 2021-02-10 | $30.29K 10-Q · filed 2021-02-10 | ||
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-28 | $30.29K 10-Q · filed 2020-10-28 | |||
| 2019-06-30 | $30.29K 10-Q · filed 2020-08-11 | ||||
| 2018-12-31 | $30.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $60.57K derived: sum of 2 quarters · filed 2020-02-10 | $90.86K 10-Q · filed 2020-02-10 | ||
| 2018-09-30 | $30.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-01 | $60.57K 10-Q · filed 2019-11-01 | |||
| 2018-06-30 | $30.29K 10-Q · filed 2019-08-14 | ||||
| 2017-12-31 | $30.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-01 | $60.57K derived: sum of 2 quarters · filed 2018-02-01 | $215.38K 10-Q · filed 2018-02-01 | ||
| 2017-09-30 | $30.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-02 | $185.09K 10-Q · filed 2017-11-02 | |||
| 2017-06-30 | $154.80K 10-Q · filed 2017-08-10 | ||||
| 2016-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-01 | $27.64K 10-Q · filed 2018-02-01 | |||
| 2016-09-30 | $27.64K 10-Q · filed 2017-11-02 | $19.00K 10-Q · filed 2016-11-10 | |||
| 2016-03-31 | -$186.28K derived: 10-Q 12 month − 10-Q 9 month · filed 2016-08-11 | -$93.14K derived: sum of 2 quarters · filed 2017-02-10 | $0.00 derived: sum of 3 quarters · filed 2017-02-10 | $93.14K 10-Q · filed 2016-08-11 | |
| 2015-12-31 | $93.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-10 | $186.28K derived: sum of 2 quarters · filed 2017-02-10 | $279.41K 10-Q · filed 2017-02-10 | $372.55K derived: sum of 4 quarters · filed 2017-02-10 | |
| 2015-09-30 | $93.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-10 | $186.28K 10-Q · filed 2016-11-10 | $279.41K derived: sum of 3 quarters · filed 2016-11-10 | ||
| 2015-06-30 | $93.14K 10-Q · filed 2015-08-13 | $186.28K derived: sum of 2 quarters · filed 2016-02-04 | |||
| 2015-03-31 | $93.14K derived: 10-Q 12 month − 10-Q 9 month · filed 2016-02-04 | $155.23K 10-Q · filed 2016-02-04 | |||
| 2014-12-31 | $62.09K 10-Q · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |